omega 3 e omega 6 – benefici per la salute del cane

Forum Gestione del cane Quotidianità omega 3 e omega 6 – benefici per la salute del cane

Questo argomento contiene 127 risposte, ha 27 partecipanti, ed è stato aggiornato da  ela 7 mesi fa.

Stai vedendo 15 articoli - dal 31 a 45 (di 128 totali)
  • Autore
    Articoli
  • #69831

    Daniele
    Utente
      • @messico

      vero se consideriamo l’affermazione nel suo complesso (e cioe se siamo interessati agli acidi grassi essenziali) ma falso se consideriamo il punto di vista generale (e cioè che le crocchette con olio di pesce sono da preferire a quelle con semi di lino);

      Io preferisco una crocchetta con olio di pesce ad una con semi di lino perché considero importanti gli Omega3. Tu mi stai dicendo che se hai davanti 2 crocchette uguali una integrata con olio di pesce e una con grani di lino (non olio di semi di lino), prendi quella con (solo) grani di lino?

      Va infine detto che sui PUFA non è ancora stata data una parola definitiva dalla scienza (sia per l’uomo che per il cane), per cui i prossimi studi sicuramente faranno chiarezza sull’argomento e potranno anche ribaltar ealcuni concetti che sono dati attulmente per certi…

      Quì stai usando 2 pesi e 2 misure: le ricerche sugli acidi grassi sono sicuramente più numerose di quelle sull’olio di semi di lino, non puoi mettere in discussione gli effetti positivi degli acidi grassi e prendere per certi quelli dei semi di lino.
      Aggiungo anche che la scienza non ha ancora dato una una parola definitiva su molti degli effetti che benefici che vengono attribuiti agli acidi grassi Omega3, ma sui testi universitari di medicina sono ampiamente accettati gli effetti sui processi neuronali, sulla fluidità delle membrane e su quella del sangue. Che poi la ricerca possa in futuro ribaltare queste affermazioni non è da escludere, ma non è di certo un singolo studio a ribaltare concetti ampiamente accettati.

      #69832

      Admin
      Admin
      • Genere: Maschio
        • @admin

        concordo, su tutto dobbiamo fare la tara: purtroppo oggigiorno ci sono fin troppe sostanze “miracolose” che vengono propinate come panacea di ogni male…

        io per esempio ho attribuito sempre tanta importanza al metilsulfenilmetano (MSM), che è un’altra di queste… come lo sono prebiotici (o probiotici?), FOS, MOS e quant’altro…

        tutte queste “rivelazioni scientifiche” vanno prese con le dovute cautele, anche perché sia l’informazione che la controinformazione raramente è del tutto disinteressata

        ;-)

        #69857

        Anonimo

          @messico
          per comprendermi devi partire dall’idea che nutro una grande stima nei confronti delle opinioni che scrivi su questo forum (e che leggo sempre con grande interesse) e, dall’idea che io integro il mangime di romeo con un eccellente olio di pesce per cui non sono contrario a dare una buona dose di omega3/6 al proprio cane; tuttavia ciò che dice Espada non è affatto infondato, e fare un affermazione come: “la crocchetta con olio di pesce è migliore di quella con semi di lino”, mi sembra (imho) spingersi troppo in là…
          primo perchè esistono numerosi studi sugli effetti benefeci dei semi di lino (e del loro olio) in umani e cani;
          secondo perche’ ‘olio di pesce’ generico, non vuol dire molto e se il mangime non è di una certa fascia, ci possiamo trovare difronte ad olii che gli omega3 ce li hanno solo sulla carta;
          in tale contesto affermo (ma specifico che è solo una mia opinione personale) che a meno che non sappia che le crocchette sono olistiche e che usino olio di salmone selvaggio o equivalenti, se dovessi andare su una crocchetta economica ne preferirei una con semi di lino (che sono abbastanza economici ) ed integrerei con un buon olio di pesce ricco di omega3 (ad es il grizzly)…
          terzo: perchè se il mio cane avesse un tumore o problemi di cuore, non avrei alcun dubbio sulla scelta, vista la potente azione dei lignani in tal ambiti…
          quarto perchè se l’olio di pesce non è lavorato in un certo modo può essere ricco di metalli pesanti (quali mercurio etc) che a lungo andare sono nocivi per i nostri amici
          quinto: perchè la vitamina ‘e’ decresce come biodisponibilità in base all’aumentare di pufa, per cui se somministriamo un mangime economico in cui la vit ‘e’ è scarsa o è calcolata prima del processo produttivo (come purtroppo molte volte mi capita di vedere), o è quella sintetica (dl-alpha-tocoferolo), potremmo trovarci a lungo andare in situazioni poco piacevoli
          sesto: perche’ studi sugli omega3 ce ne sono molti è vero; purtroppo però sempre più studi documentano e mettono in guardia contro i numerosi danni in cani e gatti causati da alimenti ricchi di omega3 (anche qui l’atteggiamento prudenziale di Espada difficilmente può essere criticato) anche perchè essendo diventata un moda, le case produttrici possono ‘abbondare’ con tutti i problemi che ben conosciamo; se desideri approfondire, ad es materiale molto attendibile, ed affascinante sull’argomento è questo:

          Potential Adverse Effects of Omega-3 Fatty Acids in Dogs and Cats
          C.E. Lenox and J.E. Bauer
          Fish oil omega-3 fatty acids, mainly eicosapentaenoic acid and docosahexaenoic acid, are used in the management of
          several diseases in companion animal medicine, many of which are inflammatory in nature. This review describes metabolic
          differences among omega-3 fatty acids and outlines potential adverse effects that may occur with their supplementation in
          dogs and cats with a special focus on omega-3 fatty acids from fish oil. Important potential adverse effects of omega-3
          fatty acid supplementation include altered platelet function, gastrointestinal adverse effects, detrimental effects on wound healing, lipid peroxidation, potential for nutrient excess and toxin exposure, weight gain, altered immune function, effects on glycemic control and insulin sensitivity, and nutrient-drug interactions.
          Key words: Dietary fat; Dietary supplements; Nutraceuticals; Nutrition.
          Fish oil omega-3 fatty acids have been investigated for benefits in management of several diseases and
          often are recommended for management of clinical problems including neoplasia,1 dermatologic disease,2–4
          hyperlipidemia,5,6 cardiovascular disease,7,8 renal disease,9,10 gastrointestinal disease,11,12 and orthopedic
          disease.13–16 Because omega-3 fatty acids are nutrients used in the management of disease, they are considered
          nutraceuticals. The term nutraceutical refers to a nutrient that has characteristics of a drug.17 Omega-3 fatty
          acids, however, are different from drugs because relatively high doses of eicosapentaenoic acid (EPA) and
          docosahexaenoic acid (DHA) are required for the treatment of disease as compared to most drugs,
          because most commercial pet foods contain a source of omega-3 fatty acids, and because DHA and possibly
          EPA are required nutrients for some lifestages (especially during growth and development). Like all drugs
          and dietary supplements, there is potential for adverse effects with usage of omega-3 fatty acids, especially
          when diets are supplemented with them or when they are present in diets in large amounts.
          Currently, there are few commercial pet foods with EPA and DHA concentrations adequate for treatment
          of disease. Joint diets, renal diets, and diets for dermatologic conditions typically contain more
          omega-3 fatty acids than maintenance diets, but even therapeutic diets may not supply enough omega-3
          fatty acids for treatment of disease. Target ranges for EPA and DHA vary quite widely for different conditions,
          but typically fall between 50 and 220 mg/kg body weight. The higher dosages often are used to
          lower serum triglyceride concentrations in patients with hypertriglyceridemia, whereas lower dosages are
          more commonly used for inflammatory conditions, renal disease, and cardiac disease. Commercial diets
          containing omega-3 fatty acids typically provide less EPA and DHA than desirable and may be advertised
          as containing omega-3 fatty acids but contain flaxseed or canola oil (rich in alpha-linolenic acid
          [ALA]) instead of fish oil. A discussion of the benefits of EPA and DHA as compared to ALA is
          included in this review. Because of the lower concentrations of EPA and DHA as compared with other
          omega-3 fatty acids and target concentrations, the authors frequently recommend supplementing EPA
          and DHA in addition to using a diet containing omega-3 fatty acids.
          The purpose of this review is to outline a number of potential adverse effects associated with use of
          omega-3 fatty acids, with special focus on adverse effects of EPA and DHA supplementation.
          This topic was reviewed by Hall in 1996,18 but the increase in research in the area in both humans and
          animals, the increase in clinical recommendations for omega-3 fatty acid supplementation, and the increase
          in commercial pet foods containing EPA and DHA make the topic important to revisit. First, basic
          concepts of fatty acid metabolism are discussed.
          Potential adverse effects that are discussed include altered platelet function, gastrointestinal adverse
          effects, detrimental effects on wound healing, lipid peroxidation, potential for nutrient excess and toxin
          exposure, weight gain, altered immune function, effects on glycemic control and insulin sensitivity,
          and nutrient-drug interactions. These adverse effects are summarized in both general and specific manners
          in Table 1.
          From the Gulf Coast Veterinary Specialists, Houston, TX (Lenox); and the Department of Small Animal Clinical Sciences and Faculty of Nutrition, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX (Bauer).
          Corresponding author: Dr. Catherine E. Lenox, Gulf Coast
          Veterinary Specialists, 1111 West Loop South Suite 140, Houston,
          TX 77027; e-mail: drlenox@gcvs.com.
          Submitted June 29, 2012; Revised October 9, 2012;
          Accepted November 21, 2012.
          Copyright © 2013 by the American College of Veterinary Internal
          Medicine

          Review
          J Vet Intern Med 2013;27:217–226
          Basic Concepts of Fatty Acid Metabolism Dietary fatty acids can be classified as saturated
          (containing no double bonds), monounsaturated (containing 1 double bond), or polyunsaturated (containing
          2 double bonds). Polyunsaturated fatty acids (PUFAs) can be classified further as omega-6 or omega-3 depending on the location of the 1st double bond from the methyl (omega) end of the molecule.
          Fatty acids frequently are described using a shorthand notation based on the number of carbons in the fatty
          acid chain, the number of double bonds in the fatty acid, and whether the fatty acid is omega-6 or omega-
          3, if applicable. For example, linoleic acid (LA) contains 18 carbons and 2 double bonds with the 1st
          double bond occurring after the 6th carbon atom from the methyl end of the structure and designated as
          18:2n-6.
          Fish oil omega-3 fatty acids are long-chain PUFAs and include EPA (20:5n-3) and DHA (22:6n-3). These
          fatty acids are characterized by 5 or 6 double bonds with the 1st one occurring between the 3rd and 4th
          carbon from the methyl end of the fatty acid chain.
          Theoretically, EPA and DHA can be derived from another omega-3 fatty acid, ALA (18:3n-3). ALA is
          found in plant products such as flaxseed oil and can be converted to EPA and DHA by desaturation (addition
          of double bonds to the fatty acid chain) and elongation (addition of an even number of carbons to the
          fatty acid chain). However, in mammals, ALA is not efficiently converted to EPA and DHA. The conversion
          rate of ALA to EPA and DHA is believed to be <10% in humans,19,20 and also is believed to be rather
          limited in dogs21,22 and cats.23,24 Therefore, when supplementing omega-3 fatty acids, fish oil is a more
          potent and efficient source of EPA and DHA as Table 1. Summary of general and specific abnormalities or adverse effects noted with usage of omega-3 fatty
          acids in dogs and cats.
          General Abnormality or Adverse Effect Specific Abnormality or Adverse Effect Implicated Fatty Acid Types and Dosesa
          Altered platelet function Decreased platelet aggregation (cats) n-6:n-3 = 1.3:1 (no specific dosage of fatty acids mentioned)38
          GI adverse effects Vomiting, diarrhea, pancreatitis EPA + DHA 0.79 and 1.98 mg/100 kcal13
          Altered wound healing Decreased epithelialization of wounds
          after five days (dogs)
          n-6:n-3 = 0.3:1 (EPA and DHA from fish oil)55
          Lipid peroxidation Increased plasma and urine thiobarbituric reactive substances
          (dogs)
          n-6:n-3 = 5.4:1 (ALA = 0.7 g/kg diet, EPA = 1.05 g/kg, and
          DHA = 0.95 g/kg)
          n-6:n-3 = 1.4:1 (ALA = 0.85 g/kg diet, EPA = 3.0 g/kg, and
          DHA = 2.65 g/kg)57
          Decreased plasma vitamin E concentration (dogs)
          n-6:n-3 = 1.4:1 (ALA, EPA, and DHA same as above)57
          Nutrient excess, toxin exposure, or both
          Consumption of heavy metals
          Consumption of chemicals such as polychlorinated biphenyls Hypervitaminosis A and D
          No clinical reports in cats or dogs. Development of clinical signs would be product and batch dependent.
          Weight gain Obesity, weight gain, or failure to induce weight loss
          No clinical reports in cats or dogs. 1 teaspoon of oil = 40–45 kcal67
          Altered immune function Decreased skin and neutrophil leukotriene B4 / increased
          leukotriene B5 (dogs)
          n-6:n-3 = 10:1 and 5:1 (blend of menhaden fish oil
          and flaxseed)69
          Decreased neutrophil leukotriene B4 / increased leukotriene B5 (dogs)
          ALA = 0.23 g/100 g diet, EPA = 3.07 g/100 g,
          DHA = 1.00 g/100 g versus ALA = 10.30 g/100 g diet and
          EPA and DHA not detected35
          Lower delayed-type hypersensitivity
          response (dogs)
          n-6:n-3 = 1.4:1 (ALA = 0.85 g/kg diet, EPA = 3.0 g/kg,
          and DHA = 2.65 g/kg)57; n-6:n-3 = 1.4:1
          (ALA = 0.5–0.6 g/kg diet, EPA = 1.9 g/kg,
          DHA = 2.2–2.5 g/kg)70
          Decreased CD4+ T lymphocyte
          count (dogs)
          n-6:n-3 = 1.4:1 (low ALA/high EPA and DHA)71
          Decreased lymphocyte proliferation
          (dogs)
          EPA 1.75 g/kg diet, DHA 2.2 g/kg diet58
          Higher skin leukotriene B5 (cats) n-6:n-3 = 5:1 (fish oil not flaxseed oil)73
          Decreased response to histamine (cats) n-6:n-3 = 5:1 (fish oil and flaxseed oil)73
          Effects on glycemic control
          and insulin sensitivity
          Improved glucose control and
          decreased serum insulin
          concentration [cats]
          EPA = 3.91% of fatty acids in diet and DHA = 4.72% versus
          EPA = 0.37% and DHA = 0.46%77
          Nutrient-drug interactions Dependent on the drug and dosage No clinical reports in cats or dogs
          aDoses reported in the same manner as the reference cited.
          218 Lenox and Bauer
          compared with products rich in ALA such as flaxseed, linseed, or canola oil. Supplementation of ALA does
          have benefits, especially in management of dermatologic disease,2 but different omega-3 fatty acids have
          different effects on the body and on disease.
          Fish oil omega-3 fatty acids are used for management of the aforementioned diseases primarily because
          of their anti-inflammatory properties. However,inflammation does not play a major role in the pathogenesis
          of all of these disorders (eg, some cardiovasculardiseases, hyperlipidemia). In these instances,
          omega-3 fatty acids are believed to have beneficial effects in addition to their role in decreasing inflammation.
          For example, omega-3 fatty acids are thought to have antitumor effects1 and effects on blood lipid
          concentrations,5,6,25 and improved receptor and ion channel functions.26,27
          Omega-6 fatty acids have a double bond between the 6th and 7th carbon from the omega-end of the fatty acid
          molecule. One of the omega-6 fatty acids is LA, which is considered essential in all mammals because of lack of
          the enzyme needed for its synthesis.24,28 Linoleic acid is efficiently converted to arachidonic acid (AA, 20:4n-6)
          in dogs, but not in cats. Delta-6 desaturase regulates the 1st step in the desaturation of essential fatty acids; it adds a double bond between the 6th and 7th carbons from the carboxyl end of the fatty acid.29 Cats have a
          dietary requirement for AA because of limited delta-6 desaturase activity.23
          Lipid metabolites, also called eicosanoids, are derived from long-chain PUFAs and include prostaglandins
          and leukotrienes. Eicosanoids can act as inflammatory mediators.30 Arachidonic acid in plasma
          membranes serves as a substrate for production of eicosanoids of the 2-series of prostaglandins and 4-series
          of leukotrienes by the action of cyclooxygenases and lipooxygenases.15,16,31 In contrast, EPA and DHA in
          plasma membranes result in production of different eicosanoids (mainly the 3-series of prostaglandins and
          5-series of leukotrienes) that are less proinflammatory compared with those derived from AA.15,16,31 The production
          of these less proinflammatory eicosanoids results in EPA and DHA being characterized as antiinflammatory.
          These effects can be observed after dietary supplementation with omega-3 fatty acids and
          after incorporation into plasma membranes of tissues.32
          When fish oil omega-3 fatty acids are administered, they can be given as a supplement separate from the
          diet (such as a liquid or capsule containing fish oil) or as part of the animal’s diet. The amount of omega-3
          fatty acids supplemented can be expressed as an absolute amount (total milligrams of EPA and DHA), a
          milligram per kilogram dosage, or as a dietary omega-6 to omega-3 (n-6:n-3) ratio. The total n-6:n-3 should be
          used with caution, because it does not reflect the total amount of omega-3 fatty acids present in the diet or
          the type of omega-3 fatty acids present.
          The total n-6:n-3 ratio has been used extensively in reports because there is competition between LA and
          ALA for enzymes that desaturate and elongate these fatty acids.33 However, this ratio should be used with
          care because, in most instances, it is calculated using total omega-3 fatty acids (ALA, EPA, and DHA). The
          use of the total omega-3 concentration is not bioequivalent to the EPA and DHA concentration, because of
          the poor conversion of ALA to EPA and DHA and because ALA does not have the same biologic effects
          as the long-chain omega-3 PUFAs. Consequently,
          many researchers consider the total intake of the in ividual omega-6 and omega-3 fatty acids to be more
          important than their ratio.33,34 The n-6:n-3 ratio can be altered in several ways. The omega-3 fatty acid
          concentration could be increased, decreased, or unchanged resulting in either an increase or decrease
          in the n-6:n-3 ratio. Waldron et al found that in dogs fed 2 different diets with the same n-6:n-3 ratio but
          with different sources of omega-3 fatty acids (linseed oil versus menhaden fish oil), neutrophil function was
          affected differently.35 Thus, the type and amount of omega-3 fatty acids are likely more influential
          compared with the total n-6:n-3 ratio.
          Although the n-6:n-3 ratio has been used primarily in many of the studies described in this review, to the
          extent possible and when reported, it will be pointed out when long-chain omega-3 PUFAs were used, when
          an unknown combination of ALA and long-chain omega-3 PUFAs was used, and how the ratio was calculated.
          Many of these adverse effects are theoretical at this time. The fact that many of the studies cited
          used the n-6:n-3 ratio as opposed to specifying the total omega-3 fatty acid dosage or EPA and DHA
          concentration make the results of many of the studies difficult to interpret with respect to actual amounts
          used.
          Altered Platelet Function
          In addition to serving as a substrate for the production of eicosanoids via cyclooxygenases and lipooxygenases,
          the presence of AA in phospholipid membranes also results in production of thromboxane
          A2, a potent platelet activator. Thromboxane A2 is essential for normal platelet function.36 The presence
          of EPA and DHA leads to production of thromboxane A3, which is a less potent platelet activator than
          thromboxane A2.37,38 Supplementation of EPA and DHA, therefore, may affect platelet activation and
          function differently than omega-6 fatty acid supplementation because of the different eicosanoids
          produced.
          Decreased platelet activity and aggregation has been detected in humans supplemented with EPA and DHA
          and may lead to an antithrombotic effect. Guillot et al dosed healthy adult men with 200–1,600 mg DHA for
          8 weeks and reported decreased platelet reactivity,39 whereas Wensing et al dosed healthy elderly humans
          with 1.6 g EPA and DHA for 6 weeks and reported decreased ex vivo platelet aggregation.40
          The effects of omega-3 fatty acids on coagulation also have been examined in cats and dogs. Two studies
          have involved cats,38,41 and the results were mixed.
          Saker et al noted prolonged bleeding time and Adverse Effects of Omega-3 Fatty Acids 219
          decreased platelet aggregation in cats after supplementation with omega-3 fatty acids at an n-6:n-3 ratio of
          1.3:1 for 16 weeks.38 The actual dosage of omega-6 and omega-3 fatty acids was not mentioned in this
          study, making results difficult to interpret. Bright et al did not document a measurable effect on hemostasis
          after supplementation of cats with EPA and DHA for 8 weeks (1.126 g EPA and 0.624 g DHA per day for
          4 weeks, then 1.689 g EPA and 0.936 g DHA per day for 4 weeks).41 This is a very large dose of EPA and
          DHA (1,800–2,800 mg/day, which is equivalent to nine 1,000-mg capsules of typical fish oil or 2 teaspoons of
          liquid fish oil daily).
          The effects of EPA and DHA have been examined in dogs and have revealed either only small changes or
          no change in platelet aggregation. Boudreaux et al fed laboratory dogs diets with differing n-6:n-3 ratios for
          12 weeks, with the lowest at an n-6:n-3 ratio of 5:1, and did note small changes in platelet reactivity, but
          did not consider them clinically relevant. No total dose of omega-3 fatty acids, but only the n-6:n-3 ratio,37
          was reported in this study. LeBlanc et al fed laboratory dogs diets with an n-6:n-3 ratio of 3.4:1 with or
          without vitamin E (again, no total dose was reported) for 12 weeks and saw no significant effects on platelet
          function.25 McNiel et al fed a diet with fish oil (EPA, 29 g/kg diet and DHA, 24 g/kg diet on dry matter
          basis) and arginine at 140 9 BW(kg)0.75 kcal metabolizable energy per day to dogs with naturally occurring
          lymphoma and hemangiosarcoma and did not see an effect on platelet aggregation or platelet count when
          compared with dogs with the same malignancies fed with a control diet rich in omega-6 fatty acids.42 In
          addition, the investigators did not note clinical bleeding at venipuncture sites or during catheter placement.
          42
          Although changes in platelet function were not seen in all 3 of the studies performed in dogs, 2 of them25,37
          did not report the total amount of omega-3 fatty acids fed, just the total n-6:n-3 ratio. Many commercial
          products contain unknown amounts of ALA, making results difficult to interpret. In addition, all of the studies
          that are currently available for review use platelet aggregometry, although other instruments such as
          thromboelastography platelet mapping and plateletfunction analyzers currently exist.43,44 The more
          recently available instrumentation may be more sensitive for detecting slight changes in platelet function.
          Future studies using defined amounts of either ALA or EPA and DHA and more sophisticated instrumentation
          will be needed to better determine any effects omega-3 fatty acids have on platelet function.
          Although omega-3 fatty acid supplements can decrease platelet aggregation, a clinically relevant effect
          on bleeding in normal humans is not expected.45 Therefore, even if there were a measurable effect of omega-3
          fatty acids on hemostasis in dogs or cats using different instrumentation, it may not be immediately clinically
          relevant. However, if mildly decreased platelet function in omega-3 fatty acid supplemented companion animal
          patients is combined with thrombocytopenia caused by disease, the mild decrease in platelet function could
          become clinically relevant.
          Gastrointestinal Adverse Effects
          Adverse gastrointestinal effects are seen frequently and are commonly reported in clinical patients supplemented
          with dietary omega-3 fatty acids. With veterinarians using high dosages of omega-3 fatty acids to
          treat clinical disease (up to EPA and DHA = 53 g/kg
          diet on dry matter basis)1,42 adverse gastrointestinal effects are a concern. If fatty acids are undigested, they
          pass into the upper gastrointestinal tract where they can act as a substrate for bacteria, and this dietary fat
          may result in secretory diarrhea.46,47 Dogs that receive omega-3 fatty acid supplements have been reported to
          develop diarrhea as an adverse effect. Adverse gastrointestinal effects, including diarrhea and vomiting, are
          reported as a reason for discontinuing supplementation in research studies.4,13 Clinical patients also develop
          gastrointestinal signs after supplementation. Roudebush et al. reported that as many as 10% of dogs with
          neoplastic disease that were fed a high-fat canned diet rich in omega-3 fatty acids in conjunction with other
          cancer therapy developed an abnormal feces consistency.
          48 Development of adverse gastrointestinal effects can occur even more frequently than reported, but the
          effects are dose-dependent. Recommendations for management of diarrhea associated with omega-3 fatty acid
          supplementation include slowly transitioning the animalto the high fat diet (or to a high dose of a dietary
          fat supplement such as concentrated omega-3 fatty acids), adding fiber to the diet, or using antibiotics.48
          Probiotics or prebiotics also could be used. Clinical patients that develop diarrhea or other adverse gastrointestinal effects may need a decreased dosage of omega-3 fatty acids as well as other dietary
          modification.
          Pancreatitis also is a concern when feeding high fat diets or high doses of fatty acid supplementation, especially
          in dogs with a known risk of pancreatitis. However,there are no reports of omega-3 fatty acid or fish
          oil supplements causing pancreatitis in dogs, cats, or humans. Theoretically, omega-3 fatty acids could
          prevent pancreatitis because of decreased blood triglyceride concentrations. An extremely high dosage of
          omega-3 fatty acids or a fish oil supplement in addition to a very high fat diet would likely be required to
          induce pancreatitis.
          Detrimental Effects on Wound Healing The stages of wound healing include inflammation, repair, and maturation.49 Although omega-3 fatty acids are beneficial for management of inflammatory diseases because of their anti-inflammatory properties, wound healing is dependent on some degree of inflammation.
          The inflammatory stage of wound healing is characterized by migration of leukocytes into the
          wounded area and is initiated within 6 hours of trauma. Cytokines are involved in this process and are
          220 Lenox and Bauer essential for attracting leukocytes to the area.49
          Because inflammation is essential for the process of wound healing, decreasing inflammation with omega-3
          fatty acids could be detrimental to patients with extensive wounds caused by trauma or in the postoperative
          period. This is a problem that could occur in addition to effects of omega-3 fatty acids on hemostasis.
          Numerous studies have been performed in rats in which researchers investigated the effects of supplemental
          omega-3 fatty acids on wound healing. As a whole, results are conflicting. Albina et al50 and Otranto
          et al51 reported that feeding rats with diets rich in omega-3 fatty acids resulted in delayed wound healing.
          However, in another study, Gercek et al did not observe detrimental effects on wound healing after parenteral
          fish oil infusion in dexamethasone-treated rats.52
          Results from studies using companion animals suggest that wound healing is not affected by omega-3
          fatty acid supplementation.53–55 Corbee et al used an omega-3 fatty acid-enriched diet in client-owned cats
          with feline chronic gingivitis and stomatitis and did not see an effect on the degree of inflammation or
          wound healing. However, the percentage of EPA and DHA in the enriched diet was relatively low (0.83%
          versus 0.10% in the control diet).53 Mooney et al made small wounds in purpose-bred dogs and did not
          observe an effect of dietary omega-3 fatty acids on wound healing.54 In these studies, the n-6:n-3 ratio
          was the main method of reporting dietary omega-3 fatty acids. The n-6:n-3 ratios ranged from 10:1 to
          40:1 (Corbee et al; EPA = 0.03–0.46% of total fatty acids, DHA = 0.07–0.37%) or from 5:1 to 100:1
          (Mooney et al; omega-3 fatty acids from fish oil and flaxseed oil = 0.4–3.4% of total fatty acids), which are
          higher ratios than that used by Albina et al (<1:1).
          The ratios do not give accurate information on the EPA and DHA concentration of the diet. The diet
          with the lower n-6:n-3 ratio in the Corbee et al study contained added fish oil, but not flaxseed oil. Mooney
          et al used a combination of fish oil and flaxseed oil to produce the final n-6:n-3 ratio reported. In another
          study on omega-3 fatty acid supplementation and wound healing, Scardino et al used a diet with an n-6:n-
          3 ratio of 0.3:1 and supplemented purpose-bred dogs for 30 days before wound formation.55 In this study, the
          dogs consuming the omega-3 fatty acid-enriched diet, which contained menhaden fish oil as the source of
          omega-3 fatty acids (actual dose not reported), had less epithelialization of open wounds after 5 days.
          There were no differences compared with the dogs consuming the control diet supplemented with soya oil
          after 10 days. These authors suggest that there may be short term, but not long-term effects on wound healing
          with high amounts of omega-3 fatty acid supplementation.
          Potential for adverse effects on wound healing may be greatest immediately after trauma or surgery. The
          effect on wound healing likely depends on the amount and type of dietary omega-3 fatty acids, the duration
          of supplementation, and the severity of the wound.
          Given these results, it may be wise to discontinue high doses of omega-3 fatty acids (either dietary or supplemental) before surgery to avoid interference with inflammation and wound healing.
          Lipid Peroxidation
          Lipid peroxidation is characterized by a free radical attack on an unsaturated fatty acid and can occur in
          the presence of oxygen.56 Long-chain highly unsaturated fatty acids such as EPA, DHA, and AA are at
          high risk to undergo peroxidation. When fish oil omega-3 fatty acids are supplemented, EPA and
          DHA accumulate in cell membranes. If antioxidants are not provided at adequate concentrations, membrane
          phospholipid fatty acids can be vulnerable to peroxidation and free radicals can form as a result.57
          Lipid peroxidation can be detrimental because of effects on the stability of cell membranes and also as
          a result of free radical attacks on proteins and DNA.18,56
          Lipid peroxidation and free radical and other byproduct formation potentially could negatively affect
          patient tolerance of dietary supplements.45 Fish oil is especially unstable because of the highly unsaturated
          fatty acids (EPA and DHA) in fish oil preparations.
          Effects of lipid peroxidation can be avoided by supplementing diets enriched in omega-3 fatty acids with
          antioxidants such as vitamin E or by adding vitamin E to omega-3 fatty acid purified supplements.18,57 Peroxidation can occur in both the product itself and within the body. Adding vitamin E (specifically alpha-tocopherol) to supplements can decrease lipid peroxidation and thus limit rancidity and increase freshness and
          shelf-life of supplements.45 Vitamin E is a hydrogen donor to free radicals and prevents oxidative damage
          to PUFAs in membranes.28 Because of the high risk for lipid peroxidation, it is prudent to check supplements
          for adequate amounts of antioxidants. It may be necessary to call the manufacturer to obtain this
          information.
          Studies on the effects of omega-3 fatty acids on lipid peroxidation are conflicting. LeBlanc et al noted no
          change in plasma lipid oxidative byproduct concentrations after 12 weeks of fish oil supplementation to
          young dogs (n-6:n-3 = 3.4:1, EPA = 1.75 g/kg diet and DHA = 2.2 g/kg diet on dry matter basis).25 In
          another study by LeBlanc et al, no changes were noted in plasma lipid peroxide concentrations feeding dogs
          the same diet the same amount of time as in the aforementioned study.58 Wander et al. noted increased
          amounts of lipid oxidative by-products (plasma and urine thiobarbituric reactive substances) after supplementing dogs with fish oil at a dietary n-6:n-3 ratio of 5.4:1 (ALA = 0.7 g/kg diet, EPA = 1.05 g/kg diet, and DHA = 0.95 g/kg diet) and 1.4:1 (ALA = 0.85 g/kg diet, EPA = 3.0 g/kg diet, and DHA = 2.65 g/kg diet).
          No adverse effects were noted in these dogs.57
          Although the clinical adverse effects of lipid peroxidation are somewhat unclear, they may be manifested
          as vitamin E deficiency. Wander et al noted decreased Adverse Effects of Omega-3 Fatty Acids 221
          plasma vitamin E concentration in dogs fed a diet enriched with fish oil using an n-6:n-3 ratio of 1.4:1.57
          Both the amount of long-chain PUFAs in a supplement or in the patient’s diet and the degree of peroxidation
          that occurs before consumption can affect requirements for vitamin E.28 Dietary vitamin E requirements increase with high concentrations of dietary PUFAs.28,59 Signs of vitamin E deficiency include
          muscle weakness caused by muscle degeneration, retinal degeneration, and steatitis, especially in cats.28
          Some authors suggest that cats will refuse diets containing peroxidized lipids60; however, there are reports
          of cats developing pansteatitis after consuming oily fish-based diets.61
          Potential for Toxin Exposure and Nutrient Excess
          Supplementation of fish oil has the potential to expose patients to environmental toxins. Consumption
          of high quantities of fish or fish oil can increase exposure to heavy metals such as mercury or chemicals
          such as polychlorinated biphenyls and polychlorodibenzodioxins.
          18,45 However, it appears that the risk of toxin exposure and related clinical signs is
          low overall.45 In Inuit preschool-aged children (in a population that consumes a large amount of fish),
          prenatal exposure to mercury, polychlorinated biphenyls, and pesticides did not cause adverse effects on
          neurologic function.62 Fish-based diets and fish oil supplements, when fed on long term, could potentially
          cause mercury toxicity.63 Clinical signs are more common in cats than dogs because of the frequency
          of feeding fish-based diets to cats, and include anorexia, ataxia, blindness, and seizures.64 Clinical signs
          of mercury toxicity in dogs include neurologic dysfunction, gastrointestinal signs including vomiting and
          death.65
          Hypervitaminosis is a concern with fish oil supplements such as cod liver oil, especially when they are
          supplemented at high dosages. Fat-soluble vitamins, especially vitamins D and A, are more of a concern
          than water-soluble vitamins because most watersoluble vitamins do not accumulate in tissue. There have
          been no reports in humans of vitamin D or A toxicity associated with fish oil supplementation and although
          the potential for toxicity exists, it is low.45,66 Even at a high dosage of supplementation such as 220 mg fish oil per kilogram body weight it would be difficult to reach the safe upper limit for vitamins D and A. The safe upper limits for a 10 kg dog are 14.6 lg cholecalciferol (584 international units) and 11,804 retinol
          equivalents of vitamin A.28
          Overall, with the diversity of therapeutic uses for fish oil, the benefits of fish oil intake likely outweigh
          the risks of toxin exposure and nutrient excess. Veterinarians should inquire about the mercury and
          toxin concentrations of fish oil supplements before prescribing them to clinical patients. Contacting the
          manufacturer may be necessary to ascertain this information.
          Weight Gain
          Although weight gain is not a commonly noted adverse effect of omega-3 fatty acid supplementation,
          the calories that oil contains should be a concern. Fat is the most energy dense nutrient when compared with
          protein or carbohydrate, and each gram of oil contains about 9 kcal.67 One teaspoon (5 ml) of oil contains
          about 42 kcal.67 Weight gain could occur when large dosages of omega-3 fatty acids are recommended, such
          as for dogs with osteoarthritis or neoplastic disease.
          Published recommendations for dogs with neoplastic disease include adding 12–20 fish oil capsules per day
          for a 10 kg dog.48 This represents 108–180 kcal of fish oil per day whereas the resting energy requirements for a 10 kg dog are <400 kcal/day. In many dogs, especially in obese or obesity-prone dogs, veterinarians
          must be cautious about the addition of large dosages of omega-3 fatty acids, either in the diet or supplemented in addition to the diet. The calories that are in the oil should be accounted for when developing a nutrition plan for these animals and if a large quantity of omega-3 fatty acids is supplemented in addition to the diet, it may unbalance the pet’s diet. One way to avoid this issue is to use a commercial diet that is supplemented with omega-3 fatty acids at the desired dosage.
          However, it is difficult to find a commercial diet containing sufficient concentrations of EPA and DHA.
          Altered Immune Function Inflammatory mediators such as prostaglandins and leukotrienes are involved in the immune response, and suppressing production of the “proinflammatory” forms of these products by supplementation of omega-3 fatty acids can alter immune function. Neutrophil functions that are mediated by leukotriene B4 can be inhibited by supplementing fish oil omega-3 fatty acids. Lee et al supplemented healthy human subjects with 5.4 g EPA and DHA daily and noted decreased production of leukotriene B4 as well as decreased chemotactic responses and adherence of neutrophils.68
          Vaughn et al noted similar effects in dogs. After supplementing various concentrations of dietary omega-3
          fatty acids from menhaden oil and flaxseed to produce n-6:n-3 ratios of 5:1, 10:1, 25:1, 50:1, and 100:1 for
          12 weeks, skin and neutrophil leukotriene B4 concentrations were decreased whereas leukotriene B5 concentrations were increased in the dogs consuming higher levels of dietary omega-3 fatty acids.69 Waldron et al investigated the effects of diets enriched in linseed oil and fish oil on neutrophil leukotriene B4 production.
          In this study, dogs fed with diets containing more EPA and DHA (the fish oil-supplemented diet,
          EPA = 3.07% diet on an as fed basis, DHA = 1.00%) had significantly lower neutrophil leukotriene B4
          production compared with dogs fed with the linseed oil-supplemented diet. In addition, dogs consuming
          menhaden fish oil had higher leukotriene B5 production compared with dogs consuming linseed oil, despite
          the fact that the 2 diets had nearly identical n-6:n-3 222 Lenox and Bauer ratios.35 However, the ex vivo nature of these studies makes determining clinical relevance of the changes in leukotriene concentrations difficult. Neutrophil function was not measured. Leukotriene B4 is an initiator
          of neutrophil recruitment, chemotaxis, and degranulation, whereas leukotriene B5 is a less active ligand at
          the leukotriene B receptor.68,69 The Waldron et al study35 provides evidence supporting the idea that not
          all omega-3 fatty acids are equal and that fatty acid composition is more important that total n-6:n-3 ratio.
          Diets supplemented with ALA are not biologically equivalent to diets supplemented with EPA and DHA.
          Omega-3 fatty acid supplementation also can affect hypersensitivity reactions as measured by the results of
          the delayed-type hypersensitivity (DTH) test. In the previously mentioned Wander et al study, researchers
          fed healthy geriatric Beagles diets with n-6:n-3 ratios of 31:1, 5.4:1, and 1:1 (the lower n-6:n-3 diets were
          supplemented with fish oil) and noted a lower DTH response in the group consuming a n-6:n-3 ratio of
          1.4:1 versus a n-6:n-3 ratio of 5.4:1 or 31:1.57 Hall et al fed healthy geriatric Beagles diets with n-6:n-3 ratios of approximately 40:1 and 1.4:1 with varying concentrations of vitamin E (alpha-tocopherol) and noted a
          suppressed DTH response in dogs fed with the lower n-6:n-3 ratio, regardless of the concentration of dietary
          vitamin E. The lower n-6:n-3 ratio was created by adding fish oil. In this study, antibody titers against a foreign protein were unaffected by diet.70
          There are other potential mechanisms of altered immune function after omega-3 fatty acid supplementation.
          Lymphocyte numbers also may be affected. In another study by Hall et al, geriatric Beagles were fed
          diets with 3 different n-6:n-3 ratios (31:1, 5.4:1, and 1.4:1) for 11 weeks. Fish oil was the source of the
          omega-3 fatty acids in the diets with lower n-6:n-3 ratios. The dogs fed with the diet with a n-6:n-3 ratio
          of 1.4:1 (EPA = 3.0 g/kg diet and DHA = 2.75 g/kg) had higher total lymphocyte counts but lower CD4+
          T lymphocyte counts, and lower CD4+ to CD8+ ratios after vaccination with foreign proteins when
          compared with dogs fed with lower dietary concentrations of omega-3 fatty acids.71 The clinical relevance
          of this decrease is uncertain despite its statistical significance.
          Hall et al also noted that neutrophil bactericidal activity was unaffected by dietary fish oil
          supplementation at varying concentrations up to EPA = 0.25% of diet on an as fed basis and
          DHA = 0.17% in healthy dogs.72 LeBlanc et al fed dogs with a diet enriched in fish oil with a n-6:n-3
          ratio of 3.4:1 (EPA = 1.75 g/kg diet, DHA = 2.2 g/kg) and noted decreased lymphocyte proliferation as measured using flow cytometry after 12 weeks.58
          There are fewer studies published on the effects of dietary fatty acid manipulation on immune function
          in cats, but results are similar to those studies performed in dogs. Park et al supplemented flaxseed oil
          and fish oil at a n-6:n-3 ratio of 5:1 and noted higher skin leukotriene B5 concentration in the cats fed
          higher dietary concentrations of fish oil, suggesting that fish oil (containing EPA and DHA) is more
          immunosuppressive than flaxseed oil (containing ALA).73 These results are similar to those of the
          Waldron et al study35 in the sense that results from both studies suggest that different omega-3 fatty acids
          have different effects.
          Although the effects of omega-3 fatty acid supplementation on immune function are not clearly known,
          there is potential for altered immune function with supplementation of omega-3 fatty acids. Whether the
          changes noted in the aforementioned studies are clinically relevant remains unknown.
          Effects on Glycemic Control and Insulin Sensitivity
          In an earlier review article on adverse effects of omega-3 fatty acid supplementation, hyperglycemia
          was listed as a potential adverse effect.18 Results of early studies performed with human subjects are mixed,
          with some authors suggesting that omega-3 fatty acid supplementation causes hyperglycemia and others indicating that omega-3 fatty acids may actually improve insulin sensitivity and glycemic control. Glauber et al74 noted a significant increase in fasting blood glucose concentration after 1 month of dietary supplementation with omega-3 fatty acids. Feskens et al,75 on the contrary, noted a protective effect of fish intake against the development of impaired glucose tolerance and diabetes mellitus in elderly human subjects. In another study, dietary omega-3 fatty acid supplementation during energy restriction resulted in improved insulin sensitivity in overweight and obese young adults.76
          In cats, authors suggest that dietary supplementation of omega-3 fatty acids results in improved insulin
          sensitivity. In one study by Wilkins et al, the authors concluded that in obese research cats, a diet with
          supplemented omega-3 fatty acids appeared to maintain insulin sensitivity.77 In this study, the omega-3
          fatty acid-enriched diet contained 1.01% ALA, 3.91% EPA, and 4.72% DHA (percentages indicate percent of
          dietary fatty acids). The control (saturated fatty acid)diet contained 0.68% ALA, 0.37% EPA, and 0.46%
          DHA.77 Another group found correlations between serum EPA concentrations and serum insulin concentrations
          in obese cats.78 Cats that had significantly higher serum EPA concentrations had lower insulin
          concentrations and vice versa. These were client-owned cats and were not consuming a standardized diet.
          Although it does not appear that supplementation of omega-3 fatty acids causes hyperglycemia in cats,
          more studies are needed before omega-3 fatty acids are recommended to diabetic patients, especially dogs. In
          addition, although improved insulin sensitivity would be beneficial in many patients, caution should be used
          in diabetic patients receiving insulin and concurrent omega-3 fatty acid supplementation.
          Nutrient–Drug Interactions In addition to direct adverse effects from omega-3 fatty acids, there is potential for nutrient-drug interactions. In humans, omega-3 fatty acids can interact with
          simvastatin to decrease blood lipid concentrations.79 In companion animals, the efficacy of some drugs, including doxorubicin, has been investigated with omega-3 fatty acid supplementation. Omega-3 fatty acids did
          not affect doxorubicin pharmacokinetics in a study performed in dogs.80 For other drugs, nutrient-drug
          interactions may exacerbate adverse effects that can occur with omega-3 fatty acid supplementation alone,
          or they may create other adverse effects not listed above. In humans, omega-3 fatty acids and aspirin
          have a synergistic effect on bleeding times when supplemented together.81 Although it seems as though
          aspirin and omega-3 fatty acids affect platelet function in different manners (irreversible inhibition versus
          competitive inhibition with AA),81 the synergistic effect of aspirin and omega-3 fatty acids on platelet function is an example of a nutrient-drug interaction. Given the frequency of omega-3 fatty acid supplementation in conjunction with nonsteroidal anti-inflammatory drug administration,14 this is one possible area for nutrientdrug interactions in dogs. Carprofen administration has been demonstrated to affect hemostasis as measured using thromboelastography.82 Concurrent administration of carprofen and omega-3 fatty acids potentially could negatively impact hemostasis similar to the combination of aspirin and omega-3 fatty acids in humans. Omega-3 fatty acids and clopidogrel may interact in a similar manner.
          Conclusion
          Currently, omega-3 fatty acids are used in managing many diseases including neoplasia,1 dermatologic disease,
          2–4 hyperlipidemia,5,6 cardiovascular disease,7,8 renal disease,9,10 gastrointestinal disease,11 and orthopedic disease.13–16 There are other disease processes or conditions for which they may be beneficial, including neurologic diseases,83 asthma,84 and behavioral issues.85 The therapeutic effects of fish oil are discussed elsewhere.86
          Adverse effects, if observed, are likely to be dosedependent.
          It is necessary to understand dosages of omega-3 fatty acids to understand how much fish oil to supplement, or what dietary concentration to aim for when recommending omega-3 supplementation.
          Provision of omega-3 fatty acids can be expressed as milligrams of total omega-3 fatty acids per kilogram
          body weight; as milligrams of EPA and DHA per kilogram body weight or metabolic body weight; as a
          dietary amount on a per energy basis (grams or milligrams per 100 or per 1,000 kcal); or as a dietary
          amount on a per weight basis (grams or milligrams per 100 grams of diet as fed or on dry matter basis). The
          amount of omega-3 fatty acids also can be expressed as a ratio of n-6:n-3 fatty acids, or as a ratio of “functional” fatty acids (LA + AA:EPA + DHA). The same enzymes are involved in metabolism of omega-6 and
          omega-3 fatty acids, resulting in competition between these fatty acids for incorporation into cell membranes
          and other biological properties. Therefore, dietary excess or deficiency of LA versus ALA may influence
          conversion rates to downstream products. Dietary amounts of omega-6 versus omega-3 fatty acids are
          frequently expressed as a dietary n-6:n-3 ratio in addition to absolute amounts for this reason. However,
          ALA is not equivalent to EPA and DHA and the total n-6:n-3 ratio by itself does not accurately describe the
          fatty acid composition of the diet. A product with a high total omega-3 fatty acid concentration could contain
          high concentrations of ALA, high concentrations of EPA and DHA, or a combination of these fatty
          acids. Because diets with ALA have different effects when compared with diets enriched in EPA and DHA,
          the type of omega-3 fatty acids is crucial information and the lack of distinction between these fatty acids
          may contribute to the equivocal nature of results of earlier studies.
          Unfortunately, all drugs, dietary supplements, or nutraceuticals have the potential for adverse effects.
          Despite the benefits listed above, there are potential risks associated with usage of omega-3 fatty acids. Clinicians should understand the adverse effects that may occur with omega-3 fatty acid supplementation, and
          that potential risks should be assessed in conjunction with the potential benefits. The National Research
          Council publication on Nutrient Requirements of Dogs and Cats indicates a safe upper limit of the combined
          amounts of EPA + DHA as 2,800 mg/1,000 kcal of diet, equivalent to 370 mg per (kg body weight)0.75
          for dogs.28 This is equivalent to 2,080 mg for a 10 kg dog. Presently, not enough published data are available
          to set a safe upper limit for cats.
          Acknowledgment
          Conflict of Interest Declaration: The authors disclose no conflict of interest.
          References
          1. Ogilvie GK, Fettman MJ, Mallinckrodt CH, et al. Effect
          of fish oil, arginine, and doxorubicin chemotherapy on
          remission and survival time for dogs with lymphoma: A doubleblind,
          randomized placebo-controlled study. Cancer 2000;88:
          1916–1928.
          2. Mueller RS, Fettman MJ, Richardson K, et al. Plasma and
          skin concentrations of polyunsaturated fatty acids before and
          after supplementation with n-3 fatty acids in dogs with atopic
          dermatitis. Am J Vet Res 2005;66:868–873.
          3. Mueller RS, Fieseler KV, Fettman MJ, et al. Effect of
          omega-3 fatty acids on canine atopic dermatitis. J Small Anim
          Pract 2004;45:293–297.
          4. Scott DW, Buerger RG. Nonsteroidal antiinflammatory
          agents in the management of canine pruritus. J Am Anim Hosp
          Assoc 1988;24:425–428.
          5. Bauer JE. Evaluation and dietary considerations in idiopathic
          hyperlipidemia in dogs. J Am Vet Med Assoc
          1995;206:1684–1688.
          6. Xenoulis PG, Steiner JM. Lipid metabolism and hyperlipidemia
          in dogs. Vet J 2010;183:12–21.
          224 Lenox and Bauer
          7. Smith CE, Freeman LM, Rush JE, et al. Omega-3 fatty
          acids in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy.
          J Vet Intern Med 2007;21:265–273.
          8. Freeman LM, Rush JE, Markwell PJ. Effects of dietary
          modification in dogs with early chronic valvular disease. J Vet
          Intern Med 2006;20:1116–1126.
          9. Brown SA, Brown CA, Crowell WA, et al. Beneficial effects
          of chronic administration of dietary omega-3 polyunsaturated
          fatty acids in dogs with renal insufficiency. J Lab Clin Med
          1998;131:447–455.
          10. Brown SA, Brown CA, Crowell WA, et al. Effects of dietary
          polyunsaturated fatty acid supplementation in early renal
          insufficiency in dogs. J Lab Clin Med 2000;135:275–286.
          11. Trepanier L. Idiopathic inflammatory bowel disease in
          cats. Rational treatment selection. J Feline Med Surg 2009;11:
          32–38.
          12. Hickman MA. Interventional nutrition for gastrointestinal
          disease. Clin Tech Small Anim Pract 1998;13:211–216.
          13. Fritsch D, Allen TA, Dodd CE, et al. Dose-titration
          effects of fish oil in osteoarthritic dogs. J Vet Intern Med
          2010;24:1020–1026.
          14. Fritsch DA, Allen TA, Dodd CE, et al. A multicenter
          study of the effect of dietary supplementation with fish oil
          omega-3 fatty acids on carprofen dosage in dogs with osteoarthritis.
          J Am Vet Med Assoc 2010;236:535–539.
          15. Roush JK, Cross AR, Renberg WC, et al. Evaluation of
          the effects of dietary supplementation with fish oil omega-3 fatty
          acids on weight bearing in dogs with osteoarthritis. J Am Vet
          Med Assoc 2010;236:67–73.
          16. Roush JK, Dodd CE, Fritsch DA, et al. Multicenter veterinary
          practice assessment of the effects of omega-3 fatty acids
          on osteoarthritis in dogs. J Am Vet Med Assoc 2010;236:59–66.
          17. Boothe DM. Nutraceuticals in veterinary medicine. Part
          I. Definitions and regulations. Compend Contin Educ Vet
          1997;19:1248–1255.
          18. Hall JA. Potential adverse effects of long-term consumption
          of (n-3) fatty acids. Compend Contin Educ Vet 1996;18:879–895.
          19. Brenna JT, Salem N Jr, Sinclair AJ, et al. Alpha-linolenic
          acid supplementation and conversion to n-3 long-chain polyunsaturated
          fatty acids in humans. Prostaglandins Leukot Essent
          Fatty Acids 2009;80:85–91.
          20. Brenna JT. Efficiency of conversion of alpha-linolenic acid
          to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab
          Care 2002;5:127–132.
          21. Bauer JE. Responses of dogs to dietary omega-3 fatty
          acids. J Am Vet Med Assoc 2007;231:1657–1661.
          22. Bauer JE, Dunbar BL, Bigley KE. Dietary flaxseed in
          dogs results in differential transport and metabolism of (n-3)
          polyunsaturated fatty acids. J Nutr 1998;128:2641S–2644S.
          23. Rivers JP, Sinclair AJ, Crawford MA. Inability of the cat
          to desaturate essential fatty acids. Nature 1975;258:171–173.
          24. Bauer JE. Metabolic basis for the essential nature of fatty
          acids and the unique dietary fatty acid requirements of cats. J
          Am Vet Med Assoc 2006;229:1729–1732.
          25. LeBlanc CJ, Bauer JE, Hosgood G, et al. Effect of dietary
          fish oil and vitamin E supplementation on hematologic and
          serum biochemical analytes and oxidative status in young dogs.
          Vet Ther 2005;6:325–340.
          26. Leaf A, Xiao YF, Kang JX, et al. Membrane effects of
          the n-3 fish oil fatty acids, which prevent fatal ventricular
          arrhythmias. J Membr Biol 2005;206:129–139.
          27. Wakutsu M, Tsunoda N, Shiba S, et al. Peroxisome proliferator-
          activated receptors (PPARs)-independent functions of
          fish oil on glucose and lipid metabolism in diet-induced obese
          mice. Lipids Health Dis 2010;9:101.
          28. NRC. Nutrient Requirements of Dogs and Cats. Washington,
          DC: The National Academies Press; 2006.
          29. Dunbar BL, Bauer JE. Metabolism of dietary essential
          fatty acids and their conversion to long-chain polyunsaturated
          metabolites. J Am Vet Med Assoc 2002;220:1621–1626.
          30. Kang JX, Weylandt KH. Modulation of inflammatory
          cytokines by omega-3 fatty acids. Subcell Biochem. 2008;49:133–
          143.
          31. Filburn CR, Griffin D. Canine plasma and erythrocyte
          response to a docosahexaenoic acid-enriched supplement: Characterization
          and potential benefits. Vet Ther 2005;6:29–42.
          32. Clandinin MT, Jumpsen J, Suh M. Relationship between
          fatty acid accretion, membrane composition, and biologic functions.
          J Pediatr 1994;125:S25–S32.
          33. Harris WS. The omega-6/omega-3 ratio and cardiovascular
          disease risk: Uses and abuses. Current atherosclerosis reports
          2006;8:453–459.
          34. Stanley JC, Elsom RL, Calder PC, et al. UK Food Standards
          Agency Workshop Report: The effects of the dietary n-6:n-3
          fatty acid ratio on cardiovascular health. Br J Nutr 2007;98:
          1305–1310.
          35. Waldron MK, Hannah SS, Bauer JE. Plasma phospholipid
          fatty acid and ex vivo neutrophil responses are differentially
          altered in dogs fed fish- and linseed-oil containing diets at the
          same n-6:n-3 fatty acid ratio. Lipids 2012;47:425–434.
          36. Thomason J, Lunsford K, Mullins K, et al. Platelet cyclooxygenase
          expression in normal dogs. J Vet Intern Med
          2011;25:1106–1112.
          37. Boudreaux MK, Reinhart GA, Vaughn DM, et al. The
          effects of varying dietary n-6 to n-3 fatty acid ratios on platelet
          reactivity, coagulation screening assays, and antithrombin III
          activity in dogs. J Am Anim Hosp Assoc 1997;33:235–243.
          38. Saker KE, Eddy AL, Thatcher CD, et al. Manipulation of
          dietary (n-6) and (n-3) fatty acids alters platelet function in cats.
          J Nutr 1998;128:2645S–2647S.
          39. Guillot N, Caillet E, Laville M, et al. Increasing intakes
          of the long-chain omega-3 docosahexaenoic acid: Effects on
          platelet functions and redox status in healthy men. FASEB J
          2009;23:2909–2916.
          40. Wensing AG, Mensink RP, Hornstra G. Effects of dietary
          n-3 polyunsaturated fatty acids from plant and marine origin on
          platelet aggregation in healthy elderly subjects. Br J Nutr
          1999;82:183–191.
          41. Bright JM, Sullivan PS, Melton SL, et al. The effects of
          n-3 fatty acid supplementation on bleeding time, plasma fatty
          acid composition, and in vitro platelet aggregation in cats. J Vet
          Intern Med 1994;8:247–252.
          42. McNiel EA, Ogilvie GK, Mallinckrodt C, et al. Platelet
          function in dogs treated for lymphoma and hemangiosarcoma
          and supplemented with dietary n-3 fatty acids. J Vet Intern Med
          1999;13:574–580.
          43. Michelson AD. Methods for the measurement of platelet
          function. Am J Cardiol 2009;103:20A–26A.
          44. Christopherson PW, Spangler EA, Boudreaux MK. Evaluation
          and clinical application of platelet function testing in small
          animal practice. Vet Clin North Am Small Anim Pract
          2012;42:173–188.
          45. Bays HE. Safety considerations with omega-3 fatty acid
          therapy. Am J Cardiol 2007;99:35C–43C.
          46. Laflamme DP, Xu H, Long GM. Effect of diets differing
          in fat content on chronic diarrhea in cats. J Vet Intern Med
          2011;25:230–235.
          47. Soong CS, Thompson JB, Poley JR, et al. Hydroxy fatty
          acids in human diarrhea. Gastroenterology 1972;63:748–757.
          48. Roudebush P, Davenport DJ, Novotny BJ. The use of
          nutraceuticals in cancer therapy. Vet Clin North Am Small Anim
          Pract 2004;34:249–269, viii.
          49. Hosgood G. Stages of wound healing and their clinical relevance.
          Vet Clin North Am Small Anim Pract 2006;36:667–685.
          Adverse Effects of Omega-3 Fatty Acids 225
          50. Albina JE, Gladden P, Walsh WR. Detrimental effects of
          an omega-3 fatty acid-enriched diet on wound healing. JPEN
          J Parenter Enteral Nutr 1993;17:519–521.
          51. Otranto M. Do Nascimento AP, Monte-Alto-Costa A.
          Effects of supplementation with different edible oils on cutaneous
          wound healing. Wound Repair Regen 2010;18:629–636.
          52. Gercek A, Yildirim O, Konya D, et al. Effects of parenteral
          fish-oil emulsion (Omegaven) on cutaneous wound healing
          in rats treated with dexamethasone. JPEN J Parenter Enteral
          Nutr 2007;31:161–166.
          53. Corbee RJ, Booij-Vrieling HE, van de Lest CH, et al.
          Inflammation and wound healing in cats with chronic gingivitis/
          stomatitis after extraction of all premolars and molars were not
          affected by feeding of two diets with different omega-6/omega-3
          polyunsaturated fatty acid ratios. J Anim Physiol Anim Nutr
          (Berl) 2012;96 (4):671–680.
          54. Mooney MA, Vaughn DM, Reinhart GA, et al. Evaluation
          of the effects of omega-3 fatty acid-containing diets on the
          inflammatory stage of wound healing in dogs. Am J Vet Res
          1998;59:859–863.
          55. Scardino MS, Swaim SF, Sartin EA, et al. The effects of
          omega-3 fatty acid diet enrichment on wound healing. Vet Dermatol
          1999;10:283–290.
          56. Spector AA. Essential fatty acids. In: Stipanuk MH, ed.
          Biochemical, Physiological, and Molecular Aspects of Human
          Nutrition. St. Louis, MO: Saunders; 2006:518–540.
          57. Wander RC, Hall JA, Gradin JL, et al. The ratio of dietary
          (n-6) to (n-3) fatty acids influences immune system function,
          eicosanoid metabolism, lipid peroxidation and vitamin E status
          in aged dogs. J Nutr 1997;127:1198–1205.
          58. LeBlanc CJ, Dietrich MA, Horohov DW, et al. Effects of
          dietary fish oil and vitamin E supplementation on canine lymphocyte
          proliferation evaluated using a flow cytometric technique.
          Vet Immunol Immunopathol 2007;119:180–188.
          59. Hendriks WH, Wu YB, Shields RG, et al. Vitamin E
          requirement of adult cats increases slightly with high dietary
          intake of polyunsaturated fatty acids. J Nutr 2002;132:1613S–
          1615S.
          60. Chamberlin A, Mitsuhashi Y, Bigley K, et al. Unexpected
          depletion of plasma arachidonate and total protein in cats fed a
          low arachidonic acid diet due to peroxidation. Br J Nutr
          2011;106(Suppl 1):S131–S134.
          61. Niza MM, Vilela CL, Ferreira LM. Feline pansteatitis
          revisited: hazards of unbalanced home-made diets. J Feline Med
          Surg 2003;5:271–277.
          62. Despres C, Beuter A, Richer F, et al. Neuromotor functions
          in Inuit preschool children exposed to Pb, PCBs, and Hg.
          Neurotoxicol Teratol 2005;27:245–257.
          63. Tegzes JH. Mercury. In: Peterson ME, Talcott PA, eds.
          Small Animal Toxicology, 2nd ed. St. Louis, MO: Saunders;
          2006:822–829.
          64. Davies TS, Nielsen SW. Pathology of subacute methylmercurialism
          in cats. Am J Vet Res 1977;38:59–67.
          65. Farrar WP, Edwards JF, Willard MD. Pathology in a dog
          associated with elevated tissue mercury concentrations. J Vet
          Diagn Invest 1994;6:511–514.
          66. Myhre AM, Carlsen MH, Bohn SK, et al. Water-miscible,
          emulsified, and solid forms of retinol supplements are more toxic
          than oil-based preparations. Am J Clin Nutr 2003;78:1152–1159.
          67. Kirby NA, Hester SL, Bauer JE. Dietary fats and the skin
          and coat of dogs. J Am Vet Med Assoc 2007;230:1641–1644.
          68. Lee TH, Hoover RL, Williams JD, et al. Effect of dietary
          enrichment with eicosapentaenoic and docosahexaenoic acids on
          in vitro neutrophil and monocyte leukotriene generation and neutrophil
          function. N Engl J Med 1985;312:1217–1224.
          69. Vaughn DM, Reinhart GA, Swaim SF, et al. Evaluation of
          effects of dietary n-6 to n-3 fatty acid ratios on leukotriene B synthesis
          in dog skin and neutrophils. Vet Dermatol 1994;5:163–173.
          70. Hall JA, Tooley KA, Gradin JL, et al. Effects of dietary
          n-6 and n-3 fatty acids and vitamin E on the immune response of
          healthy geriatric dogs. Am J Vet Res 2003;64:762–772.
          71. Hall JA, Wander RC, Gradin JL, et al. Effect of dietary
          n-6-to-n-3 fatty acid ratio on complete blood and total white
          blood cell counts, and T-cell subpopulations in aged dogs. Am J
          Vet Res 1999;60:319–327.
          72. Hall JA, Chinn RM, Vorachek WR, et al. Influence of
          dietary antioxidants and fatty acids on neutrophil mediated bacterial
          killing and gene expression in healthy Beagles. Vet Immunol
          Immunopathol 2011;139:217–228.
          73. Park HJ, Park JS, Hayek MG, et al. Dietary fish oil and
          flaxseed oil suppress inflammation and immunity in cats. Vet
          Immunol Immunopathol 2011;141:301–306.
          74. Glauber H, Wallace P, Griver K, et al. Adverse metabolic
          effect of omega-3 fatty acids in non-insulin-dependent diabetes
          mellitus. Ann Intern Med 1988;108:663–668.
          75. Feskens EJ, Bowles CH, Kromhout D. Inverse association
          between fish intake and risk of glucose intolerance in normoglycemic
          elderly men and women. Diabetes Care 1991;14:935–941.
          76. Ramel A, Martinez A, Kiely M, et al. Beneficial effects of
          long-chain n-3 fatty acids included in an energy-restricted diet on
          insulin resistance in overweight and obese European young
          adults. Diabetologia 2008;51:1261–1268.
          77. Wilkins C, Long RC Jr, Waldron M, et al. Assessment of
          the influence of fatty acids on indices of insulin sensitivity and
          myocellular lipid content by use of magnetic resonance spectroscopy
          in cats. Am J Vet Res 2004;65:1090–1099.
          78. Mazaki-Tovi M, Abood SK, Schenck PA. Effect of
          omega-3 fatty acids on serum concentrations of adipokines in
          healthy cats. Am J Vet Res 2011;72:1259–1265.
          79. Davidson MH, Stein EA, Bays HE, et al. Efficacy and
          tolerability of adding prescription omega-3 fatty acids 4 g/d to
          simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week,
          randomized, double-blind, placebo-controlled study. Clin Ther
          2007;29:1354–1367.
          80. Selting KA, Ogilvie GK, Gustafson DL, et al. Evaluation
          of the effects of dietary n-3 fatty acid supplementation on the
          pharmacokinetics of doxorubicin in dogs with lymphoma. Am J
          Vet Res 2006;67:145–151.
          81. Harris WS, Silveira S, Dujovne CA. The combined effects
          of N-3 fatty acids and aspirin on hemostatic parameters in man.
          Thromb Res 1990;57:517–526.
          82. Brainard BM, Meredith CP, Callan MB, et al. Changes in
          platelet function, hemostasis, and prostaglandin expression after
          treatment with nonsteroidal anti-inflammatory drugs with various
          cyclooxygenase selectivities in dogs. Am J Vet Res 2007;68:
          251–257.
          83. Scorza FA, Cavalheiro EA, Arida RM, et al. Positive
          impact of omega-3 fatty acid supplementation in a dog with
          drug-resistant epilepsy: A case study. Epilepsy & Behavior: E&B
          2009;15:527–528.
          84. Leemans J, Cambier C, Chandler T, et al. Prophylactic
          effects of omega-3 polyunsaturated fatty acids and luteolin on
          airway hyperresponsiveness and inflammation in cats with experimentally-
          induced asthma. Vet J 2010;184:111–114.
          85. Re S, Zanoletti M, Emanuele E. Aggressive dogs are characterized
          by low omega-3 polyunsaturated fatty acid status. Vet
          Res Commun 2008;32:225–230.
          86. Bauer JE. Therapeutic use of fish oils in companion
          animals. J Am Vet Med Assoc 2011;239:1441–1451.
          226 Lenox and Bauer

          ps. forse conviene spostare la discussione in un post sugli omega 3:P

          #69866

          Daniele
          Utente
            • @messico

            Comprendo il tuo punto di vista (ti ringrazio per la stima, che è comunque reciproca), forse la mia affermazione era un po’ superficiale, ogni situazione va valutata separatamente tenendo conto del cane che si deve alimentare.

            Non conoscevo le proprietà dei lignani, cercherò di documentarmi un po’. Comunque mi reputo anche io un conservatore, preferisco non seguire le mode e rimanere cauto nelle integrazioni. Domani mi leggo l’articolo che hai postato.

            #73393

            Admin
            Admin
            • Genere: Maschio
              • @admin

              ricopio anche qui questo prezioso riscontro

              Ho letto con piacere il topic che mi hai consigliato sugli omega3/6: visto che sono un medico (…di umani),vi posso confermare che ormai gli omega 3/6 stanno passando di moda, parchè, ad esempio,inibiscono la cagulazione delle piastrine, si ossidano facilmente, qs vale nche per l’olio di lino,aumentano troppo la permeabilità delle membrane cellulari, possono dare aritmia. Io li prescrivo per periodi di integrazione brevi e consiglio che è MOLTO meglio assumerli dagli alimenti. Servono invece dal quarto mese di gravidanza. fino a tutto il primo anno di vita per la maturazione del sistema nervoso. Si è visto che sciolgono le protesi valvolari cardiache. Quindi, visto che il cane fra tutti gli animali è il più simile all’ uomo per composizione delle membrane cellulari….infatti è l’ unico animale che come noi si ammala di depressione. Ci sono dei ricercatori che hanno notato che in estate la concentrazione di omega 3 nel sangue di cane aumenta, questo si pensa che possa accadereper il fatto che, poichè gli omega inibiscono la coagulazione delle piastrine, il microrganismo della filaria, che appunto è più infettante d’estate e favorisce che le piastrine si aggreghino, circola nel sangue con più difficoltà:sarebbe un autodifesa che il cane mette in atto contro la filaria.

              #84706

              agostinof
              Utente
                • @agostinof

                La spirulina l’ho usata per un anno, la compravo in Inghilterra ma sinceramente non mi sembra che serva

                #84709

                furaha
                Utente
                  • @furaha

                  Se la dieta é bilanciata, non serve. Io uso l’alga klamath (che é meglio della spirulina), come fonte di prebiotici.

                  #84711

                  Admin
                  Admin
                  • Genere: Maschio
                    • @admin

                    secondo me dovrebbe essere VIETATO PER LEGGE di somministrare al cane integratori così costosi come le alghe di cui state parlando, ma anche certi olii non meno pregiati.

                    già c’é TROPPA SPECULAZIONE nel mercato dell’alimentazione complementare umana, non incoraggiamo lo spreco (da parte dei consumatori) e l’approfittarne (da parte dei venditori)?

                    sulle alghe “supercibi” ci sono altri riferimenti anche nel topic:
                    https://www.canedifamiglia.com/index.php/forum/16-quotidianita/13830-integratori-alimentari-per-cani-vitamine-minerali-aminoacidi

                    #86596

                    sampei
                    Utente
                      • @sampei

                      io nei periodi caldi utilizzo l’olio vivo active che dovrebbe avere, oltre che proprietà antiparassitarie (contro i flebotomi), anche un apporto di vitamine e omega 3 ed omega 6
                      conoscete questo prodotto?

                      voi fareste qualche integrazione anche in questo periodo (o comunque anche eventualmente in sostituzione dell’olio vivo active)

                      alla prossima visita (tra un paio di mesi) voglio sottoporre alcune questioni al mio vet e ci voglio arrivare preparato… infatti sto leggendo e cercando info anche sui condroprotettori (ho già trovato un paio di discussioni sul forum ed eventualmente chiederò alcune cose lì)
                      comunque si tratta di un cane di piccola taglia che ha superato gli 8 anni, e qualche volta mi sembra accenni una leggera zoppia anteriore “random”

                      #86708

                      agostinof
                      Utente
                        • @agostinof

                        Una volta usavo lo Zosma come intergatore, la sua formulazione è (era) studiata per il pelo…qualcuno di voi lo conosce?
                        Simile alla farina al sapore di Miele, il suo impiego originario era per migliorare il pelo degli animali da pelliccia, poi ha subito una sorta di evoluzione per gli animali da compagnia.

                        Ho smesso di usarlo per via del prezzo troppo proibitivo..

                        #87283

                        mccaw
                        Moderatore
                          • @mccaw

                          Ieri in un programma medico hanno detto che gli omega 6 sono probabilmente pro-infiammatori e per questo motivo devono essere in giusto rapporto con gli omega 3 che sono antinfiammatori. Ho cercato qua e la ma sembra che queste proprietà infiammatorie degli omega 6 siano state verificate esclusivamente in vitro mentre sul campo non vi siano evidenze scientifiche. Comunque nel dubbio meglio avere un rapporto omega3-6 da 1:3 a 1:5 che vengono da più parti indicati come gli estremi ottimali.

                          #87297

                          ursula
                          Utente
                            • @ursula

                            Ciao a tutti, mi chiamo Gabriella e mi sono appena iscritta. Da qualche tempo uso un integratore di Omega-3 EPA/DHA e vitamina E (ad uso umano, lo stesso che uso io) anche nella dieta di Ursula, la mia Rottweiler di 10 anni, che pare avere problemi di colite (la diagnosi è ancora incerta), con buoni risultati sull’intestino, insieme ad un probiotico, sempre ad uso umano, che comunque ha dato ottimi risultati anche per patologie renali su cane e gatto.
                            Mi sono permessa di intervenire in questa discussione per scrivere che io stessa sono riuscita a curare malattie considerate incurabili (non tumori) e fortemente invalidanti mie personali grazie all’uso di mineralli e vitamine.
                            Non è semplice scegliere nel mare di speculazioni che vi è su determinati tipi di alimenti/integratori, ho notato infatti che esattamente come in umana anche per gli animali le aziende speculano parecchio e spesso comprando le materie prime si risparmia in maniera considerevole.
                            Ma venendo all’argomento della discussione, l’integratore che ho scelto è uno dei pochi che è certificato IFOS, perchè con il discorso metalli pesanti a mio parere è meglio non scherzare.
                            Per i miei animali se posso cerco di dargli quello che si è rivelato utile per me.
                            Anch’io non credo che esista un unico alimento che possa considerarsi la panacea di ogni male, però sono fermamente convinta, per quello che ho riscontrato sulla mia salute e di altre persone che hanno adottato un’integrazione come la mia, che esiste la possibilità con una corretta sinergia tra minerali e vitamine di migliorare sensibilmente la propria qualità di vita.

                            #87319

                            espada
                            Utente
                              • @espada

                              grazie Ursula, domani ti invio in messaggio privato altre discussioni in cui magari hai qualche elemento da condividere (es. su fitoterapici, ecc.)

                              #87374

                              mccaw
                              Moderatore
                                • @mccaw

                                Da qualche tempo uso un integratore di Omega-3 EPA/DHA e vitamina E (ad uso umano, lo stesso che uso io)

                                Puoi dirci il nome del prodotto?

                                #87403

                                ursula
                                Utente
                                  • @ursula

                                  Ciao Espada e McCaw, mi scuso se non ho scritto subito il nome del prodotto.
                                  Si tratta di Omegor Vitality 1000, uno dei pochi integratori in umana che ha il certificato IFOS.
                                  Troverete in Rete tante testimonianze di persone entusiaste di questo integratore, io lo uso personalmente e lo trovo ottimo, i veterinari me lo hanno approvato.
                                  Una scatola da 45 perle da 1410 mg mi costa € 15,00, ad Ursula ne do una al giorno in uno dei pasti quotidiani.
                                  Il suo pelo è bello lucido e pare che questo integratore la stia aiutando molto a livello intestinale.
                                  Usandolo anch’io posso dirvi che non vi torna su il sapore di pesce, come può succedere con altri integratori dello stesso tipo, in definitiva a me e a lei sta facendo bene.
                                  Altra nota positiva, l’olio di semi di lino spremuto a freddo (verificate sempre che chi lo vende rispetti questa catena di refrigerazione) può non essere gradito agli animali, con le perle il problema è completamente risolto.
                                  In più la presenza di vitamina E naturale è un’ottima cosa per loro (come anche per noi), la vitamina E ha un ruolo importante nella circolazione e non solo.

                                  Se la mia esperienza personale può tornare utile la offro volentieri ;-)

                                Stai vedendo 15 articoli - dal 31 a 45 (di 128 totali)

                                Devi essere loggato per rispondere a questa discussione.

                                  Ultime Discussioni